☰

Roger D. Weiss - Publications

Affiliations: 
Mass General Hospital and Harvard University 
Tree Info Similar researchers PubMed Report error

278 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 McHugh RK, Fitzmaurice GM, Votaw VR, Geyer RB, Ragnini K, Greenfield SF, Weiss RD. Cognitive behavioral therapy for anxiety and opioid use disorder: Development and pilot testing. Journal of Substance Use and Addiction Treatment. 160: 209296. PMID 38272120 DOI: 10.1016/j.josat.2024.209296  0.313
2023 Rosansky JA, Howard L, Goodman H, Okst K, Fatkin T, Fredericksen AK, Sokol R, Gardiner P, Parry G, Cook BL, Weiss RD, Schuman-Olivier ZD. Effects of live-online, group mindfulness training on opioid use and anxiety during buprenorphine treatment: A comparative effectiveness RCT. Contemporary Clinical Trials. 107417. PMID 38135210 DOI: 10.1016/j.cct.2023.107417  0.304
2023 Luo SX, Feaster DJ, Liu Y, Balise RR, Hu MC, Bouzoubaa L, Odom GJ, Brandt L, Pan Y, Hser YI, VanVeldhuisen P, Castillo F, Calderon AR, Rotrosen J, Saxon AJ, ... Weiss RD, et al. Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment. Jama Psychiatry. PMID 37792357 DOI: 10.1001/jamapsychiatry.2023.3596  0.313
2023 Castillo F, Hu MC, Liu Y, Balise RR, Weiss RD, Rotrosen J, Nunes EV, Saxon AJ, Feaster DJ, Luo SX. Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances. Drug and Alcohol Dependence. 251: 110926. PMID 37604012 DOI: 10.1016/j.drugalcdep.2023.110926  0.303
2023 Thakrar AP, Pytell JD, Stoller KB, Walters V, Weiss RD, Chander G. Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder. Journal of Substance Use and Addiction Treatment. 150: 209055. PMID 37088398 DOI: 10.1016/j.josat.2023.209055  0.339
2022 Pan Y, Feaster DJ, Odom G, Brandt L, Hu MC, Weiss RD, Rotrosen J, Saxon AJ, Luo SX, Balise RR. Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment. Drug and Alcohol Dependence Reports. 5. PMID 36644227 DOI: 10.1016/j.dadr.2022.100128  0.316
2022 Suzuki J, Martin B, Prostko S, Chai PR, Weiss RD. Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study. Integrative Medicine Reports. 1: 157-163. PMID 36105269 DOI: 10.1089/imr.2022.0070  0.313
2022 Karnik NS, Marsden J, McCluskey C, Boley RA, Bradley KA, Campbell CI, Curtis ME, Fiellin D, Ghitza U, Hefner K, Hser YI, McHugh RK, McPherson SM, Mooney LJ, Moran LM, ... ... Weiss RD, et al. The Opioid Use Disorder Core Outcomes Set (OUD-COS) for treatment research: findings from a Delphi consensus study. Addiction (Abingdon, England). PMID 35293064 DOI: 10.1111/add.15875  0.34
2021 McHugh RK, Hilton BT, Chase AM, Griffin ML, Weiss RD. Do people with opioid use disorder and posttraumatic stress disorder benefit from dding Individual opioid Drug Counseling to buprenorphine? Drug and Alcohol Dependence. 228: 109084. PMID 34607194 DOI: 10.1016/j.drugalcdep.2021.109084  0.32
2021 Sugarman DE, Busch AB, McHugh RK, Bogunovic OJ, Trinh CD, Weiss RD, Greenfield SF. Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic. The American Journal On Addictions. PMID 34405475 DOI: 10.1111/ajad.13207  0.305
2021 Kneeland ET, Peckham AD, McHugh RK, Weiss RD, Beard C, Björgvinsson T. Tobacco Use Predicts Treatment Dropout and Outcome in an Acute, Transdiagnostic Psychiatric Treatment Setting. Behavior Therapy. 52: 897-906. PMID 34134829 DOI: 10.1016/j.beth.2020.11.002  0.302
2021 Shulman M, Weiss R, Rotrosen J, Novo P, Costello E, Nunes EV. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)". Addiction Science & Clinical Practice. 16: 15. PMID 33676577 DOI: 10.1186/s13722-021-00223-z  0.321
2020 McHugh RK, Trinh CD, Griffin ML, Weiss RD. Validation of the craving scale in a large sample of adults with substance use disorders. Addictive Behaviors. 113: 106651. PMID 33086155 DOI: 10.1016/j.addbeh.2020.106651  0.3
2020 Suzuki J, Weiss RD. Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence? Journal of Addiction Medicine. PMID 32909980 DOI: 10.1097/Adm.0000000000000711  0.423
2020 McHugh RK, Geyer RB, Chase AR, Griffin ML, Bogunovic O, Weiss RD. Sex differences in benzodiazepine misuse among adults with substance use disorders. Addictive Behaviors. 112: 106608. PMID 32861991 DOI: 10.1016/J.Addbeh.2020.106608  0.405
2020 McHugh RK, Votaw VR, Taghian NR, Griffin ML, Weiss RD. Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use. Journal of Substance Abuse Treatment. 117: 108061. PMID 32811622 DOI: 10.1016/J.Jsat.2020.108061  0.353
2020 Peckham AD, Griffin ML, McHugh RK, Weiss RD. Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder. Drug and Alcohol Dependence. 213: 108122. PMID 32563846 DOI: 10.1016/J.Drugalcdep.2020.108122  0.411
2020 King CD, Hilton BT, Greenfield SF, McHugh RK, Griffin ML, Weiss RD, Ressler KJ. Anxiety sensitivity and grit as mediators between childhood abuse and relapse risk for substance use. Child Abuse & Neglect. 107: 104568. PMID 32559552 DOI: 10.1016/J.Chiabu.2020.104568  0.464
2020 Votaw VR, Witkiewitz K, Vowles KE, Weiss RD, Griffin ML, McHugh RK. Pain interference and catastrophizing are not associated with polysubstance use among treatment-seeking patients with substance use disorders and chronic pain. The American Journal of Drug and Alcohol Abuse. 1-9. PMID 32529847 DOI: 10.1080/00952990.2020.1757687  0.324
2020 Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, ... ... Weiss RD, et al. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and Alcohol Dependence. 107993. PMID 32360455 DOI: 10.1016/J.Drugalcdep.2020.107993  0.318
2020 Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply. Journal of Addiction Medicine. PMID 32187110 DOI: 10.1097/Adm.0000000000000651  0.381
2020 Connery HS, Weiss RD. Discontinuing Buprenorphine Treatment of Opioid Use Disorder: What Do We (Not) Know? The American Journal of Psychiatry. 177: 104-106. PMID 32008394 DOI: 10.1176/Appi.Ajp.2019.19121245  0.444
2020 Fitzmaurice GM, Lipsitz SR, Weiss RD. Within-treatment frequency of use versus abstinence as a predictor of longitudinal post-treatment follow-up assessments of drug use. Drug and Alcohol Dependence. 208: 107857. PMID 31968301 DOI: 10.1016/J.Drugalcdep.2020.107857  0.403
2020 Suzuki J, Robinson D, Mosquera M, Solomon DA, Montgomery MW, Price CD, Johnson JA, Martin B, Liebschutz JW, Schnipper JL, Weiss RD. Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis. The American Journal On Addictions. PMID 31930608 DOI: 10.1111/Ajad.13000  0.356
2019 Copersino ML, Patel R, Price JS, Visser KF, Vitaliano G, Plitman E, Lukas SE, Weiss RD, Janes AC, Chakravarty MM. Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entry. Drug and Alcohol Dependence. 107728. PMID 31740207 DOI: 10.1016/J.Drugalcdep.2019.107728  0.385
2019 McDermott KA, Griffin ML, McHugh RK, Fitzmaurice GM, Jamison RN, Provost SE, Weiss RD. Long-term naturalistic follow-up of chronic pain in adults with prescription opioid use disorder. Drug and Alcohol Dependence. 205: 107675. PMID 31715440 DOI: 10.1016/J.Drugalcdep.2019.107675  0.307
2019 Beard C, Peckham AD, Griffin ML, Weiss RD, Taghian N, McHugh RK. Associations among interpretation bias, craving, and abstinence self-efficacy in adults with substance use disorders. Drug and Alcohol Dependence. 205: 107644. PMID 31698320 DOI: 10.1016/J.Drugalcdep.2019.107644  0.41
2019 Kleykamp BA, De Santis M, Dworkin RH, Huhn AS, Kampman KM, Montoya ID, Preston KL, Ramey T, Smith SM, Turk DC, Walsh R, Weiss RD, Strain EC. Craving and opioid use disorder: A scoping review. Drug and Alcohol Dependence. 205: 107639. PMID 31683241 DOI: 10.1016/J.Drugalcdep.2019.107639  0.412
2019 Suzuki J, Johnson JA, Montgomery MW, Hayden MC, Price CN, Solomon DA, Liebschutz JM, Schnipper JL, Weiss RD. Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. Journal of Addiction Medicine. PMID 31634202 DOI: 10.1097/Adm.0000000000000572  0.36
2019 Connery HS, Taghian N, Kim J, Griffin M, Rockett IRH, Weiss RD, Kathryn McHugh R. Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder. Drug and Alcohol Dependence. 205: 107612. PMID 31627077 DOI: 10.1016/J.Drugalcdep.2019.107612  0.392
2019 Kleykamp BA, Weiss RD, Strain EC. Time to Reconsider the Role of Craving in Opioid Use Disorder. Jama Psychiatry. PMID 31339512 DOI: 10.1001/Jamapsychiatry.2019.1839  0.407
2019 Kelly JF, Hoffman L, Vilsaint C, Weiss R, Nierenberg A, Hoeppner B. Peer support for mood disorder: Characteristics and benefits from attending the Depression and Bipolar Support Alliance mutual-help organization. Journal of Affective Disorders. 255: 127-135. PMID 31150942 DOI: 10.1016/J.Jad.2019.05.039  0.351
2019 Weiss RD, Griffin ML, Marcovitz DE, Hilton BT, Fitzmaurice GM, McHugh RK, Carroll KM. Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence. The Journal of Clinical Psychiatry. 80. PMID 30920187 DOI: 10.4088/Jcp.18M12292  0.361
2019 Dickey B, Azeni H, Weiss R, Sederer L. Schizophrenia, substance use disorders and medical co-morbidity. The Journal of Mental Health Policy and Economics. 3: 27-33. PMID 11967434 DOI: 10.1002/1099-176X(200003)3:1<27::Aid-Mhp67>3.0.Co;2-P  0.371
2018 Faberman J, Provost SE, Weiss RD, Greenfield SF. Focus Group Study to Examine Content of Family Meetings in Short-term Substance Use Disorder Treatment. Journal of Social Work Practice in the Addictions. 18: 231-248. PMID 30505244 DOI: 10.1080/1533256X.2018.1488720  0.349
2018 Connery HS, Weiss RD. Microscopes and Telescopes: the Societal Impact of Substance Use Disorder Treatment. The American Journal of Psychiatry. 175: 925-926. PMID 30269546 DOI: 10.1176/Appi.Ajp.2018.18060694  0.452
2018 Fitzmaurice GM, Lipsitz SR, Weiss RD. Sensitivity analysis for non-monotone missing binary data in longitudinal studies: Application to the NIDA collaborative cocaine treatment study. Statistical Methods in Medical Research. 962280218794725. PMID 30146938 DOI: 10.1177/0962280218794725  0.339
2018 McHugh RK, Geyer R, Karakula S, Griffin ML, Weiss RD. Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use. The American Journal On Addictions. PMID 30028048 DOI: 10.1111/Ajad.12765  0.412
2018 Welsh JW, Tretyak V, McHugh RK, Weiss RD, Bogunovic O. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers. Drug and Alcohol Dependence. 189: 96-107. PMID 29906718 DOI: 10.1016/J.Drugalcdep.2018.04.028  0.411
2018 Kiluk BD, Fitzmaurice GM, Strain EC, Weiss RD. What Defines a Clinically Meaningful Outcome in the Treatment of Substance Use Disorders: Reductions in Direct Consequences of Drug Use or Improvement in Overall Functioning? Addiction (Abingdon, England). PMID 29900624 DOI: 10.1111/Add.14289  0.429
2017 Fitzmaurice GM, Lipsitz SR, Weiss RD. Statistical considerations in the choice of endpoint for drug use disorder trials. Drug and Alcohol Dependence. 181: 219-222. PMID 29102827 DOI: 10.1016/J.Drugalcdep.2017.09.031  0.384
2017 Medlock MM, Rosmarin DH, Connery HS, Griffin ML, Weiss RD, Karakula SL, McHugh RK. Religious coping in patients with severe substance use disorders receiving acute inpatient detoxification. The American Journal On Addictions. PMID 28836712 DOI: 10.1111/Ajad.12606  0.437
2017 Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, Guara G, O'Connor K, Alford DP, Parker V, Weiss RD, Samet JH, Crosson J, Cushman PA, Lasser KE. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial. Jama Internal Medicine. PMID 28715535 DOI: 10.1001/Jamainternmed.2017.2468  0.303
2017 Kathryn McHugh R, Votaw VR, Barlow DH, Fitzmaurice GM, Greenfield SF, Weiss RD. Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods. Contemporary Clinical Trials. PMID 28689852 DOI: 10.1016/J.Cct.2017.07.006  0.469
2017 Greenfield SF, Weiss RD. Addiction-25 Years Later. Harvard Review of Psychiatry. 25: 97-100. PMID 28475500 DOI: 10.1097/Hrp.0000000000000159  0.313
2017 Weiss RD, Rao V. The Prescription Opioid Addiction Treatment Study: What have we learned. Drug and Alcohol Dependence. 173: S48-S54. PMID 28363320 DOI: 10.1016/J.Drugalcdep.2016.12.001  0.379
2017 McHugh RK, Votaw VR, Fulciniti F, Connery HS, Griffin ML, Monti PM, Weiss RD. Perceived barriers to smoking cessation among adults with substance use disorders. Journal of Substance Abuse Treatment. 74: 48-53. PMID 28132700 DOI: 10.1016/J.Jsat.2016.12.008  0.335
2017 Mackie SE, McHugh RK, McDermott K, Griffin ML, Winkelman JW, Weiss RD. Prevalence of restless legs syndrome during detoxification from alcohol and opioids. Journal of Substance Abuse Treatment. 73: 35-39. PMID 28017182 DOI: 10.1016/J.Jsat.2016.10.001  0.335
2017 Weiss R, Griffin ML, McDermott K, McHugh K, Karakula SL, Fitzmaurice G. Pain severity and subsequent opioid use during buprenorphine-naloxone treatment of prescription opioid-dependent patients with chronic pain Drug and Alcohol Dependence. 171: e215-e216. DOI: 10.1016/J.Drugalcdep.2016.08.589  0.319
2017 McHugh K, Greenfield SF, Weiss R. Development and pilot test of integrated cognitive behavioral therapy for anxiety and opioid use disorder Drug and Alcohol Dependence. 171: e139. DOI: 10.1016/J.Drugalcdep.2016.08.384  0.371
2016 Carroll KM, Weiss RD. The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. The American Journal of Psychiatry. appiajp201616070792. PMID 27978771 DOI: 10.1176/Appi.Ajp.2016.16070792  0.365
2016 Karakula SL, Weiss RD, Griffin ML, Borges AM, Bailey AJ, McHugh RK. Delay discounting in opioid use disorder: Differences between heroin and prescription opioid users. Drug and Alcohol Dependence. 169: 68-72. PMID 27776247 DOI: 10.1016/J.Drugalcdep.2016.10.009  0.386
2016 Griffin ML, McDermott KA, McHugh RK, Fitzmaurice GM, Weiss RD. Grit in patients with substance use disorders. The American Journal On Addictions. PMID 27759947 DOI: 10.1111/Ajad.12460  0.423
2016 McHugh RK, Votaw VR, Bogunovic O, Karakula SL, Griffin ML, Weiss RD. Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder. Addictive Behaviors. PMID 27575980 DOI: 10.1016/J.Addbeh.2016.08.020  0.426
2016 Votaw VR, Wittenauer J, Connery HS, Weiss RD, McHugh RK. Perceived risk of heroin use among nonmedical prescription opioid users. Addictive Behaviors. PMID 27544695 DOI: 10.1016/J.Addbeh.2016.08.025  0.318
2016 Griffin ML, McDermott KA, McHugh RK, Fitzmaurice GM, Jamison RN, Weiss RD. Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain. Drug and Alcohol Dependence. PMID 27161860 DOI: 10.1016/J.Drugalcdep.2016.04.023  0.34
2016 McHugh RK, Weiss RD, Cornelius M, Martel MO, Jamison RN, Edwards RR. Distress Intolerance and Prescription Opioid Misuse among Patients with Chronic Pain. The Journal of Pain : Official Journal of the American Pain Society. PMID 27058161 DOI: 10.1016/J.Jpain.2016.03.004  0.305
2016 Sylvia LG, Gold AK, Stange JP, Peckham AD, Deckersbach T, Calabrese JR, Weiss RD, Perlis RH, Nierenberg AA, Ostacher MJ. A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 25: 94-8. PMID 26894822 DOI: 10.1111/Ajad.12346  0.415
2016 McHugh RK, Fulciniti F, Mashhoon Y, Weiss RD. Cue-induced craving to paraphernalia and drug images in opioid dependence. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 26848719 DOI: 10.1111/Ajad.12344  0.341
2015 Nosyk B, Bray JW, Wittenberg E, Aden B, Eggman AA, Weiss RD, Potter J, Ang A, Hser YI, Ling W, Schackman BR. Short term health-related quality of life improvement during opioid agonist treatment. Drug and Alcohol Dependence. PMID 26511766 DOI: 10.1016/J.Drugalcdep.2015.10.009  0.334
2015 Keuroghlian AS, Reisner SL, White JM, Weiss RD. Substance use and treatment of substance use disorders in a community sample of transgender adults. Drug and Alcohol Dependence. 152: 139-46. PMID 25953644 DOI: 10.1016/J.Drugalcdep.2015.04.008  0.394
2015 Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 10-4. PMID 25823630 DOI: 10.1111/Ajad.12161  0.341
2015 Weiss RD, Potter JS, Griffin ML, Provost SE, Fitzmaurice GM, McDermott KA, Srisarajivakul EN, Dodd DR, Dreifuss JA, McHugh RK, Carroll KM. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. Drug and Alcohol Dependence. 150: 112-9. PMID 25818060 DOI: 10.1016/J.Drugalcdep.2015.02.030  0.389
2015 Griffin ML, Bennett HE, Fitzmaurice GM, Hill KP, Provost SE, Weiss RD. Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 308-14. PMID 25808055 DOI: 10.1111/Ajad.12188  0.389
2015 DeVido J, Bogunovic O, Weiss RD. Alcohol use disorders in pregnancy Harvard Review of Psychiatry. 23: 112-121. PMID 25747924 DOI: 10.1097/Hrp.0000000000000070  0.308
2015 Hearon BA, Pierce CL, Björgvinsson T, Fitzmaurice GM, Greenfield SF, Weiss RD, Busch AB. Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen. The American Journal of Drug and Alcohol Abuse. 41: 173-6. PMID 25700005 DOI: 10.3109/00952990.2015.1005309  0.363
2015 McDermott KA, Griffin ML, Connery HS, Hilario EY, Fiellin DA, Fitzmaurice GM, Weiss RD. Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. The Journal of Clinical Psychiatry. 76: 189-94. PMID 25562462 DOI: 10.4088/Jcp.14M09096  0.376
2015 Northrup TF, Stotts AL, Green C, Potter JS, Marino EN, Walker R, Weiss RD, Trivedi M. Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model. Addictive Behaviors. 41: 20-8. PMID 25282598 DOI: 10.1016/J.Addbeh.2014.09.021  0.327
2015 McHugh RK, Nielsen S, Weiss RD. Prescription drug abuse: from epidemiology to public policy. Journal of Substance Abuse Treatment. 48: 1-7. PMID 25239857 DOI: 10.1016/J.Jsat.2014.08.004  0.372
2015 Potter JS, Dreifuss JA, Marino EN, Provost SE, Dodd DR, Rice LS, Fitzmaurice GM, Griffin ML, Weiss RD. The multi-site prescription opioid addiction treatment study: 18-month outcomes. Journal of Substance Abuse Treatment. 48: 62-9. PMID 25189089 DOI: 10.1016/J.Jsat.2014.07.009  0.395
2015 Hilario EY, Griffin ML, McHugh RK, McDermott KA, Connery HS, Fitzmaurice GM, Weiss RD. Denial of urinalysis-confirmed opioid use in prescription opioid dependence. Journal of Substance Abuse Treatment. 48: 85-90. PMID 25115135 DOI: 10.1016/J.Jsat.2014.07.003  0.354
2015 Price JS, Copersino ML, Vitaliano G, Lukas SE, Weiss R, Janes A. Brain default mode network functional connectivity in polysubstance using emerging adults during opioid dependence treatment Drug and Alcohol Dependence. 156: e181. DOI: 10.1016/J.Drugalcdep.2015.07.675  0.351
2015 McHugh K, Edwards RR, Jamison RN, Cornelius MC, Weiss R. Distress intolerance and prescription opioid abuse in chronic pain patients Drug and Alcohol Dependence. 156: e146-e147. DOI: 10.1016/J.Drugalcdep.2015.07.400  0.332
2015 Weiss R, McDermott K, Griffin ML, Hilario E, Connery H. Does early response to buprenorphine-naloxone predict treatment outcome in prescription opioid dependence? Drug and Alcohol Dependence. 146: e19. DOI: 10.1016/J.Drugalcdep.2014.09.733  0.317
2014 McHugh RK, Fitzmaurice GM, Carroll KM, Griffin ML, Hill KP, Wasan AD, Weiss RD. Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug and Alcohol Dependence. 145: 121-6. PMID 25454409 DOI: 10.1016/J.Drugalcdep.2014.10.002  0.42
2014 Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 25376754 DOI: 10.1002/Ajad.12161.X  0.341
2014 McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, et al. Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemporary Clinical Trials. 39: 211-23. PMID 25179587 DOI: 10.1016/J.Cct.2014.08.011  0.39
2014 Levy S, Weiss R, Sherritt L, Ziemnik R, Spalding A, Van Hook S, Shrier LA. An electronic screen for triaging adolescent substance use by risk levels. Jama Pediatrics. 168: 822-8. PMID 25070067 DOI: 10.1001/Jamapediatrics.2014.774  0.332
2014 Macias Konstantopoulos WL, Dreifuss JA, McDermott KA, Parry BA, Howell ML, Mandler RN, Fitzmaurice GM, Bogenschutz MP, Weiss RD. Identifying patients with problematic drug use in the emergency department: results of a multisite study. Annals of Emergency Medicine. 64: 516-25. PMID 24999283 DOI: 10.1016/J.Annemergmed.2014.05.012  0.364
2014 Schuman-Olivier Z, Weiss RD, Hoeppner BB, Borodovsky J, Albanese MJ. Emerging adult age status predicts poor buprenorphine treatment retention. Journal of Substance Abuse Treatment. 47: 202-12. PMID 24953168 DOI: 10.1016/J.Jsat.2014.04.006  0.343
2014 Suzuki J, Matthews ML, Brick D, Nguyen MT, Wasan AD, Jamison RN, Ellner AL, Tishler LW, Weiss RD. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically. Journal of Opioid Management. 10: 159-68. PMID 24944066 DOI: 10.5055/Jom.2014.0204  0.334
2014 Weiss RD, Griffin ML, Potter JS, Dodd DR, Dreifuss JA, Connery HS, Carroll KM. Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management? Drug and Alcohol Dependence. 140: 118-22. PMID 24831754 DOI: 10.1016/J.Drugalcdep.2014.04.005  0.395
2014 Weiss RD, Potter JS, Griffin ML, McHugh RK, Haller D, Jacobs P, Gardin J, Fischer D, Rosen KD. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. Journal of Substance Abuse Treatment. 47: 140-5. PMID 24814051 DOI: 10.1016/J.Jsat.2014.03.004  0.327
2014 McHugh RK, Sugarman DE, Kaufman JS, Park S, Weiss RD, Greenfield SF. Readability of self-report alcohol misuse measures. Journal of Studies On Alcohol and Drugs. 75: 328-34. PMID 24650827 DOI: 10.15288/Jsad.2014.75.328  0.301
2014 McHugh RK, Park S, Weiss RD. Cue-induced craving in dependence upon prescription opioids and heroin. The American Journal On Addictions. 23: 453-8. PMID 24628912 DOI: 10.1111/J.1521-0391.2014.12129.X  0.339
2014 Weiss RD. Behavioural treatment combined with buprenorphine does not reduce opioid use compared with buprenorphine alone. Evidence-Based Mental Health. 17: e2. PMID 24591547 DOI: 10.1136/Eb-2013-101639  0.366
2014 McHugh RK, Hu MC, Campbell AN, Hilario EY, Weiss RD, Hien DA. Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disorders. Journal of Traumatic Stress. 27: 82-9. PMID 24473926 DOI: 10.1002/Jts.21878  0.331
2014 Meade CS, Bevilacqua LA, Moore ED, Griffin ML, Gardin JG, Potter JS, Hatch-Maillette M, Weiss RD. Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 27-33. PMID 24313238 DOI: 10.1111/J.1521-0391.2013.12057.X  0.328
2014 Griffin ML, Dodd DR, Potter JS, Rice LS, Dickinson W, Sparenborg S, Weiss RD. Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. The American Journal of Drug and Alcohol Abuse. 40: 157-62. PMID 24219166 DOI: 10.3109/00952990.2013.842241  0.465
2014 Nielsen S, Hillhouse M, Weiss RD, Mooney L, Sharpe Potter J, Lee J, Gourevitch MN, Ling W. The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample. The American Journal On Addictions. 23: 343-8. PMID 24112096 DOI: 10.1111/J.1521-0391.2013.12105.X  0.324
2014 Stotts A, Northrup T, Potter JS, Marino EN, Walker R, Trivedi M, Weiss R. Relations between craving and withdrawal and time to first opioid use among prescription opioid abusers initiating buprenorphine detoxification Drug and Alcohol Dependence. 140: e218. DOI: 10.1016/J.Drugalcdep.2014.02.605  0.359
2014 McHugh RK, Park S, Weiss R. Cue-induced craving in prescription opioid and heroin dependence Drug and Alcohol Dependence. 140: e141. DOI: 10.1016/J.Drugalcdep.2014.02.400  0.303
2014 Copersino ML, Frederick B, Janes A, Frost K, Hurley-Dorof W, Faberman J, Weiss R, Lukas SE. Medial prefrontal cortex gray matter volume is associated with lifetime substance use severity in abstinent addiction treatment patients Drug and Alcohol Dependence. 140: e38. DOI: 10.1016/J.Drugalcdep.2014.02.126  0.338
2013 Smith SM, Dart RC, Katz NP, Paillard F, Adams EH, Comer SD, Degroot A, Edwards RR, Haddox JD, Jaffe JH, Jones CM, Kleber HD, Kopecky EA, Markman JD, Montoya ID, ... ... Weiss RD, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 154: 2287-96. PMID 23792283 DOI: 10.1016/J.Pain.2013.05.053  0.328
2013 Kiluk BD, Dreifuss JA, Weiss RD, Horigian VE, Carroll KM. Psychometric properties of a Spanish-language version of the Short Inventory of Problems. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 27: 893-900. PMID 23772760 DOI: 10.1037/A0032805  0.346
2013 Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ. Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes. Drug and Alcohol Dependence. 132: 580-6. PMID 23688843 DOI: 10.1016/J.Drugalcdep.2013.04.006  0.349
2013 Hill KP, Bennett HE, Griffin ML, Connery HS, Fitzmaurice GM, Subramaniam G, Woody GE, Weiss RD. Association of cannabis use with opioid outcomes among opioid-dependent youth. Drug and Alcohol Dependence. 132: 342-5. PMID 23528523 DOI: 10.1016/J.Drugalcdep.2013.02.030  0.361
2013 Levy B, Medina AM, Weiss RD. Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal study. Comprehensive Psychiatry. 54: 618-26. PMID 23357126 DOI: 10.1016/J.Comppsych.2012.12.018  0.336
2013 Dreifuss JA, Griffin ML, Frost K, Fitzmaurice GM, Potter JS, Fiellin DA, Selzer J, Hatch-Maillette M, Sonne SC, Weiss RD. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug and Alcohol Dependence. 131: 112-8. PMID 23333292 DOI: 10.1016/J.Drugalcdep.2012.12.010  0.371
2013 McHugh RK, Devito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. Journal of Substance Abuse Treatment. 45: 38-43. PMID 23313145 DOI: 10.1016/J.Jsat.2012.12.007  0.399
2013 Kiluk BD, Dreifuss JA, Weiss RD, Morgenstern J, Carroll KM. The Short Inventory of Problems - revised (SIP-R): psychometric properties within a large, diverse sample of substance use disorder treatment seekers. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 27: 307-14. PMID 22642856 DOI: 10.1037/A0028445  0.405
2012 Farren CK, Hill KP, Weiss RD. Bipolar disorder and alcohol use disorder: a review. Current Psychiatry Reports. 14: 659-66. PMID 22983943 DOI: 10.1007/S11920-012-0320-9  0.433
2012 DeVido JJ, Weiss RD. Treatment of the depressed alcoholic patient Current Psychiatry Reports. 14: 610-618. PMID 22907336 DOI: 10.1007/S11920-012-0314-7  0.394
2012 Turk DC, O'Connor AB, Dworkin RH, Chaudhry A, Katz NP, Adams EH, Brownstein JS, Comer SD, Dart R, Dasgupta N, Denisco RA, Klein M, Leiderman DB, Lubran R, Rappaport BA, ... ... Weiss RD, et al. Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain. 153: 1997-2008. PMID 22770841 DOI: 10.1016/J.Pain.2012.05.029  0.388
2012 Copersino ML, Schretlen DJ, Fitzmaurice GM, Lukas SE, Faberman J, Sokoloff J, Weiss RD. Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure. The American Journal of Drug and Alcohol Abuse. 38: 246-50. PMID 22443860 DOI: 10.3109/00952990.2012.670866  0.368
2012 Putnins SI, Griffin ML, Fitzmaurice GM, Dodd DR, Weiss RD. Poor sleep at baseline predicts worse mood outcomes in patients with co-occurring bipolar disorder and substance dependence. The Journal of Clinical Psychiatry. 73: 703-8. PMID 22313797 DOI: 10.4088/Jcp.11M07007  0.371
2012 Wasan AD, Ross EL, Michna E, Chibnik L, Greenfield SF, Weiss RD, Jamison RN. Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial. The Journal of Pain : Official Journal of the American Pain Society. 13: 146-54. PMID 22245713 DOI: 10.1016/J.Jpain.2011.10.010  0.343
2012 Kolodziej ME, Muchowski PM, Hamdi NR, Morrissette P, McGowan AJ, Weiss RD. Adaptation of the patient feedback survey at a community treatment setting. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 21: 63-71. PMID 22211348 DOI: 10.1111/J.1521-0391.2011.00197.X  0.387
2011 Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Archives of General Psychiatry. 68: 1238-46. PMID 22065255 DOI: 10.1001/Archgenpsychiatry.2011.121  0.334
2011 Subramaniam GA, Warden D, Minhajuddin A, Fishman MJ, Stitzer ML, Adinoff B, Trivedi M, Weiss R, Potter J, Poole SA, Woody GE. Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. Journal of the American Academy of Child and Adolescent Psychiatry. 50: 1120-8. PMID 22024000 DOI: 10.1016/J.Jaac.2011.07.010  0.406
2011 Potter JS, Donovan DM, Weiss RD, Gardin J, Lindblad R, Wakim P, Dodd D. Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection. The American Journal of Drug and Alcohol Abuse. 37: 400-7. PMID 21854283 DOI: 10.3109/00952990.2011.596975  0.358
2011 Teter CJ, Falone AE, Bakaian AM, Tu C, Ongür D, Weiss RD. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Research. 190: 253-8. PMID 21696830 DOI: 10.1016/J.Psychres.2011.05.042  0.366
2011 Hamdi NR, Levy M, Jaffee WB, Chisholm SM, Weiss RD. Implementing an adapted version of the job seekers' workshop in a residential program for patients with substance use disorders. Journal of Addiction Medicine. 5: 148-52. PMID 21643458 DOI: 10.1097/Adm.0B013E3181E95Eb2  0.433
2011 McDonald LJ, Griffin ML, Kolodziej ME, Fitzmaurice GM, Weiss RD. The impact of drug use in social networks of patients with substance use and bipolar disorders. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 20: 100-5. PMID 21314751 DOI: 10.1111/J.1521-0391.2010.00117.X  0.35
2011 Levy B, Medina AM, Manove E, Weiss RD. The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder. Journal of Psychiatric Research. 45: 1048-54. PMID 21306735 DOI: 10.1016/J.Jpsychires.2011.01.005  0.308
2011 Zanarini MC, Frankenburg FR, Frankenbur FR, Weingeroff JL, Reich DB, Fitzmaurice GM, Weiss RD. The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. Addiction (Abingdon, England). 106: 342-8. PMID 21083831 DOI: 10.1111/J.1360-0443.2010.03176.X  0.41
2011 Meade CS, Fitzmaurice GM, Sanchez AK, Griffin ML, McDonald LJ, Weiss RD. The relationship of manic episodes and drug abuse to sexual risk behavior in patients with co-occurring bipolar and substance use disorders: a 15-month prospective analysis. Aids and Behavior. 15: 1829-33. PMID 20859672 DOI: 10.1007/S10461-010-9814-9  0.386
2011 Levy B, Medina AM, Hintz K, Weiss RD. Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder. Psychiatry Research. 185: 353-7. PMID 20674041 DOI: 10.1016/J.Psychres.2010.06.010  0.343
2011 Levy B, Manove E, Weiss R. P01-223-Recovery of cognitive functioning in patients with co-occurring bipolar disorder and alcohol dependence during early remission from an acute mood episode European Psychiatry. 26: 224-224. DOI: 10.1016/S0924-9338(11)71934-4  0.39
2010 Upadhyay J, Maleki N, Potter J, Elman I, Rudrauf D, Knudsen J, Wallin D, Pendse G, McDonald L, Griffin M, Anderson J, Nutile L, Renshaw P, Weiss R, Becerra L, et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain : a Journal of Neurology. 133: 2098-114. PMID 20558415 DOI: 10.1093/Brain/Awq138  0.337
2010 Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE. HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study. Journal of Acquired Immune Deficiency Syndromes (1999). 55: 65-72. PMID 20393347 DOI: 10.1097/Qai.0B013E3181D916Db  0.323
2010 Liebschutz JM, Saitz R, Weiss RD, Averbuch T, Schwartz S, Meltzer EC, Claggett-Borne E, Cabral H, Samet JH. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. The Journal of Pain : Official Journal of the American Pain Society. 11: 1047-55. PMID 20338815 DOI: 10.1016/J.Jpain.2009.10.012  0.373
2010 Potter JS, Chakrabarti A, Domier CP, Hillhouse MP, Weiss RD, Ling W. Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network. Journal of Substance Abuse Treatment. 38: S80-6. PMID 20307799 DOI: 10.1016/J.Jsat.2009.12.007  0.309
2010 Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, et al. From research to the real world: Buprenorphine in the decade of the Clinical Trials Network Journal of Substance Abuse Treatment. 38. PMID 20307796 DOI: 10.1016/J.Jsat.2010.01.009  0.383
2010 Weiss RD, Potter JS, Copersino ML, Prather K, Jacobs P, Provost S, Chim D, Selzer J, Ling W. Conducting clinical research with prescription opioid dependence: defining the population. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 19: 141-6. PMID 20163386 DOI: 10.1111/J.1521-0391.2009.00017.X  0.353
2010 Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W. A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology. Contemporary Clinical Trials. 31: 189-99. PMID 20116457 DOI: 10.1016/J.Cct.2010.01.003  0.381
2010 Potter JS, Prather K, Kropp F, Byrne M, Sullivan CR, Mohamedi N, Copersino ML, Weiss RD. A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. Contemporary Clinical Trials. 31: 185-8. PMID 20079463 DOI: 10.1016/J.Cct.2010.01.002  0.342
2010 Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I, Weiss RD, Sachs GS. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry. 167: 289-97. PMID 20008948 DOI: 10.1176/Appi.Ajp.2009.09020299  0.452
2010 Chakrabarti A, Woody GE, Griffin ML, Subramaniam G, Weiss RD. Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. Drug and Alcohol Dependence. 107: 253-6. PMID 19948382 DOI: 10.1016/J.Drugalcdep.2009.10.014  0.346
2010 Levy B, Weiss RD. Neurocognitive impairment and psychosis in bipolar I disorder during early remission from an acute episode of mood disturbance. The Journal of Clinical Psychiatry. 71: 201-6. PMID 19925749 DOI: 10.4088/Jcp.08M04663Yel  0.368
2010 Douglas KR, Chan G, Gelernter J, Arias AJ, Anton RF, Weiss RD, Brady K, Poling J, Farrer L, Kranzler HR. Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. Addictive Behaviors. 35: 7-13. PMID 19720467 DOI: 10.1016/J.Addbeh.2009.07.004  0.414
2010 Meade CS, Lukas SE, McDonald LJ, Fitzmaurice GM, Eldridge JA, Merrill N, Weiss RD. A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification. Journal of Substance Abuse Treatment. 38: 12-21. PMID 19574017 DOI: 10.1016/J.Jsat.2009.05.010  0.356
2009 Jaffee WB, Bailey GL, Lohman M, Riggs P, McDonald L, Weiss RD. Methods of recruiting adolescents with psychiatric and substance use disorders for a clinical trial. The American Journal of Drug and Alcohol Abuse. 35: 381-4. PMID 20180668 DOI: 10.1080/00952990903150860  0.387
2009 Kalayasiri R, Gelernter J, Farrer L, Weiss R, Brady K, Gueorguieva R, Kranzler HR, Malison RT. Adolescent cannabis use increases risk for cocaine-induced paranoia. Drug and Alcohol Dependence. 107: 196-201. PMID 19944543 DOI: 10.1016/J.Drugalcdep.2009.10.006  0.371
2009 Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid cognitive screening of patients with substance use disorders. Experimental and Clinical Psychopharmacology. 17: 337-44. PMID 19803633 DOI: 10.1037/A0017260  0.34
2009 Weiss RD, Griffin ML, Jaffee WB, Bender RE, Graff FS, Gallop RJ, Fitzmaurice GM. A "community-friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug and Alcohol Dependence. 104: 212-9. PMID 19573999 DOI: 10.1016/J.Drugalcdep.2009.04.018  0.445
2009 Wu LT, Ringwalt CL, Weiss RD, Blazer DG. Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use. Drug and Alcohol Dependence. 104: 156-66. PMID 19500920 DOI: 10.1016/J.Drugalcdep.2009.04.014  0.419
2009 Levy B, Weiss RD. Cognitive functioning in bipolar and co-occurring substance use disorders: a missing piece of the puzzle. Harvard Review of Psychiatry. 17: 226-30. PMID 19499421 DOI: 10.1080/10673220902979870  0.438
2009 Levy B, Stephansky MR, Dobie KC, Monzani BA, Medina AM, Weiss RD. The duration of inpatient admission predicts cognitive functioning at discharge in patients with bipolar disorder. Comprehensive Psychiatry. 50: 322-6. PMID 19486730 DOI: 10.1016/J.Comppsych.2008.09.005  0.362
2009 Hughes JR, Weiss RD. Are differences in guidelines for the treatment of nicotine dependence and non-nicotine dependence justified? Addiction (Abingdon, England). 104: 1951-7. PMID 19426290 DOI: 10.1111/J.1360-0443.2009.02561.X  0.308
2009 McGovern MP, Lambert-Harris C, Acquilano S, Xie H, Alterman AI, Weiss RD. A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders. Addictive Behaviors. 34: 892-7. PMID 19395179 DOI: 10.1016/J.Addbeh.2009.03.009  0.433
2009 Meade CS, McDonald LJ, Graff FS, Fitzmaurice GM, Griffin ML, Weiss RD. A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders. Bipolar Disorders. 11: 425-33. PMID 19392857 DOI: 10.1111/J.1399-5618.2009.00682.X  0.424
2009 Wasan AD, Butler SF, Budman SH, Fernandez K, Weiss RD, Greenfield SF, Jamison RN. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? The Clinical Journal of Pain. 25: 193-8. PMID 19333168 DOI: 10.1097/Ajp.0B013E318193A6C4  0.349
2009 Griffin ML, Kolodziej ME, Weiss RD. Measuring principal substance of abuse in comorbid patients for clinical research Addictive Behaviors. 34: 826-829. PMID 19285810 DOI: 10.1016/J.Addbeh.2009.03.002  0.475
2009 Farrer LA, Kranzler HR, Yu Y, Weiss RD, Brady KT, Anton R, Cubells JF, Gelernter J. Association of variants in MANEA with cocaine-related behaviors. Archives of General Psychiatry. 66: 267-74. PMID 19255376 DOI: 10.1001/Archgenpsychiatry.2008.538  0.308
2009 Zhang H, Kranzler HR, Weiss RD, Luo X, Brady KT, Anton RF, Farrer LA, Gelernter J. Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biological Psychiatry. 66: 128-36. PMID 19217079 DOI: 10.1016/J.Biopsych.2008.12.021  0.359
2009 Jaffee WB, Griffin ML, Gallop R, Meade CS, Graff F, Bender RE, Weiss RD. Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. The Journal of Clinical Psychiatry. 70: 171-6. PMID 19192456 DOI: 10.4088/Jcp.08M04011  0.434
2009 Ford JD, Gelernter J, DeVoe JS, Zhang W, Weiss RD, Brady K, Farrer L, Kranzler HR. Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. Drug and Alcohol Dependence. 99: 193-203. PMID 18775607 DOI: 10.1016/J.Drugalcdep.2008.07.004  0.468
2008 Weiss RD. Identifying and diagnosing co-occurring disorders. Cns Spectrums. 13: 4-6. PMID 19317016 DOI: 10.1017/S1092852900002893  0.377
2008 Weiss RD, O'malley SS, Hosking JD, Locastro JS, Swift R. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study. Journal of Studies On Alcohol and Drugs. 69: 878-84. PMID 18925346 DOI: 10.15288/Jsad.2008.69.878  0.304
2008 Bieber CM, Fernandez K, Borsook D, Brennan MJ, Butler SF, Jamison RN, Osgood E, Sharpe-Potter J, Thomson HN, Weiss RD, Katz NP. Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Experimental and Clinical Psychopharmacology. 16: 429-34. PMID 18837639 DOI: 10.1037/1064-1297.16.5.429  0.345
2008 Ernst DB, Pettinati HM, Weiss RD, Donovan DM, Longabaugh R. An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care. Annals of Family Medicine. 6: 435-40. PMID 18779548 DOI: 10.1370/Afm.884  0.314
2008 Levy B, Monzani BA, Stephansky MR, Weiss RD. Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care. Psychiatry Research. 161: 28-35. PMID 18752854 DOI: 10.1016/J.Psychres.2007.09.009  0.373
2008 Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, Farrer L, Kranzler HR. Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addictive Behaviors. 33: 1199-207. PMID 18558465 DOI: 10.1016/J.Addbeh.2008.05.003  0.369
2008 Paul D, Sullivan MA, Weiss RD. Response: providing relief, avoiding euphoria. Addiction Science & Clinical Practice. 4: 26-7. PMID 18497714 DOI: 10.1151/Ascp084226  0.321
2008 Worley M, Gallop R, Gibbons MB, Ring-Kurtz S, Present J, Weiss RD, Crits-Christoph P. Additional treatment services in a cocaine treatment study: level of services obtained and impact on outcome. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 209-17. PMID 18463998 DOI: 10.1080/10550490802021994  0.381
2008 Yu Y, Kranzler HR, Panhuysen C, Weiss RD, Poling J, Farrer LA, Gelernter J. Substance dependence low-density whole genome association study in two distinct American populations. Human Genetics. 123: 495-506. PMID 18438686 DOI: 10.1007/S00439-008-0501-0  0.396
2008 Potter JS, Prather K, Weiss RD. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. The American Journal On Addictions. 17: 121-5. PMID 18393055 DOI: 10.1080/10550490701862902  0.373
2008 Jaffee WB, Trucco E, Teter C, Levy S, Weiss RD. Focus on alcohol & drug abuse: ensuring validity in urine drug testing. Psychiatric Services (Washington, D.C.). 59: 140-2. PMID 18245154 DOI: 10.1176/Ps.2008.59.2.140  0.328
2008 Graff FS, Griffin ML, Weiss RD. Predictors of dropout from group therapy among patients with bipolar and substance use disorders Drug and Alcohol Dependence. 94: 272-275. PMID 18162331 DOI: 10.1016/J.Drugalcdep.2007.11.002  0.429
2008 Potter JS, Shiffman SJ, Weiss RD. Chronic pain severity in opioid-dependent patients. The American Journal of Drug and Alcohol Abuse. 34: 101-7. PMID 18161648 DOI: 10.1080/00952990701523706  0.375
2008 Meade CS, Graff FS, Griffin ML, Weiss RD. HIV risk behavior among patients with co-occurring bipolar and substance use disorders: Associations with mania and drug abuse Drug and Alcohol Dependence. 92: 296-300. PMID 17850993 DOI: 10.1016/J.Drugalcdep.2007.07.013  0.366
2008 Kolodziej ME, Griffin ML, Bender R, Weiss RD. Assessment of depressive symptom severity among patients with co-occurring bipolar disorder and substance dependence Journal of Affective Disorders. 106: 83-89. PMID 17602752 DOI: 10.1016/J.Jad.2007.05.024  0.369
2007 Bender RE, Griffin ML, Gallop RJ, Weiss RD. Assessing negative consequences in patients with substance use and bipolar disorders: psychometric properties of the short inventory of problems (SIP). The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 16: 503-9. PMID 18058418 DOI: 10.1080/10550490701641058  0.441
2007 Pomykacz B, Mao M, Weiss RD, Teter CJ. A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder. Harvard Review of Psychiatry. 15: 259-263. PMID 17924260 DOI: 10.1080/10673220701650383  0.397
2007 Katz NP, Adams EH, Chilcoat H, Colucci RD, Comer SD, Goliber P, Grudzinskas C, Jasinski D, Lande SD, Passik SD, Schnoll SH, Sellers E, Travers D, Weiss R. Challenges in the development of prescription opioid abuse-deterrent formulations. The Clinical Journal of Pain. 23: 648-60. PMID 17885342 DOI: 10.1097/Ajp.0B013E318125C5E8  0.36
2007 Manwani SG, Szilagyi KA, Zablotsky B, Hennen J, Griffin ML, Weiss RD. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders Journal of Clinical Psychiatry. 68: 1172-1176. PMID 17854240 DOI: 10.4088/Jcp.V68N0802  0.411
2007 Kranzler HR, Wilcox M, Weiss RD, Brady K, Hesselbrock V, Rounsaville B, Farrer L, Gelernter J. The validity of cocaine dependence subtypes. Addictive Behaviors. 33: 41-53. PMID 17582692 DOI: 10.1016/J.Addbeh.2007.05.011  0.347
2007 Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. The American Journal of Psychiatry. 164: 5-123. PMID 17569411  0.356
2007 Weiss RD, Griffin ML, Kolodziej ME, Greenfield SF, Najavits LM, Daley DC, Doreau HR, Hennen JA. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. The American Journal of Psychiatry. 164: 100-7. PMID 17202550 DOI: 10.1176/Ajp.2007.164.1.100  0.664
2007 Meade CS, Weiss RD. Substance Abuse as a Risk Factor for HIV Sexual Risk Behavior Among Persons With Severe Mental Illness: Review of Evidence and Exploration of Mechanisms Clinical Psychology: Science and Practice. 14: 23-33. DOI: 10.1111/J.1468-2850.2007.00059.X  0.333
2006 Ostacher MJ, Nierenberg AA, Perlis RH, Eidelman P, Borrelli DJ, Tran TB, Marzilli Ericson G, Weiss RD, Sachs GS. The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. The Journal of Clinical Psychiatry. 67: 1907-11. PMID 17194268 DOI: 10.4088/Jcp.V67N1210  0.363
2006 Weiss RD, Kueppenbender KD. Combining psychosocial treatment with pharmacotherapy for alcohol dependence. Journal of Clinical Psychopharmacology. 26: S37-42. PMID 17114954 DOI: 10.1097/01.Jcp.0000248604.58305.B3  0.333
2006 Kleber HD, Weiss RD, Anton RF, Rounsaville BJ, George TP, Strain EC, Greenfield SF, Ziedonis DM, Kosten TR, Hennessy G, O'Brien CP, Connery HS, McIntyre JS, et al. Treatment of patients with substance use disorders, second edition. American Psychiatic Association. The American Journal of Psychiatry. 163: 5-82. PMID 16981488  0.346
2006 Harned MS, Najavits LM, Weiss RD. Self-harm and suicidal behavior in women with comorbid PTSD and substance dependence. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 15: 392-5. PMID 16966196 DOI: 10.1080/10550490600860387  0.6
2006 Najavits LM, Gallop RJ, Weiss RD. Seeking safety therapy for adolescent girls with PTSD and substance use disorder: a randomized controlled trial. The Journal of Behavioral Health Services & Research. 33: 453-63. PMID 16858633 DOI: 10.1007/S11414-006-9034-2  0.653
2006 Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. The British Journal of Psychiatry : the Journal of Mental Science. 189: 20-5. PMID 16816301 DOI: 10.1192/Bjp.Bp.104.007773  0.394
2006 Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, ... ... Weiss RD, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. Jama. 295: 2003-17. PMID 16670409 DOI: 10.1001/Jama.295.17.2003  0.327
2006 Fossey MD, Otto MW, Yates WR, Wisniewski SR, Gyulai L, Allen MH, Miklowitz DJ, Coon KA, Ostacher MJ, Neel JL, Thase ME, Sachs GS, Weiss RD. Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 15: 138-43. PMID 16595351 DOI: 10.1080/10550490500528423  0.428
2006 Kalayasiri R, Kranzler HR, Weiss R, Brady K, Gueorguieva R, Panhuysen C, Yang BZ, Farrer L, Gelernter J, Malison RT. Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs. Drug and Alcohol Dependence. 84: 77-84. PMID 16413147 DOI: 10.1016/J.Drugalcdep.2005.12.002  0.307
2006 Barber JP, Gallop R, Crits-Christoph P, Frank A, Thase ME, Weiss RD, Beth Connolly Gibbons M. The role of therapist adherence, therapist competence, and alliance in predicting outcome of individual drug counseling: Results from the National Institute Drug Abuse Collaborative Cocaine Treatment Study Psychotherapy Research. 16: 229-240. DOI: 10.1080/10503300500288951  0.384
2005 Najavits LM, Schmitz M, Gotthardt S, Weiss RD. Seeking Safety plus Exposure Therapy: an outcome study on dual diagnosis men. Journal of Psychoactive Drugs. 37: 425-35. PMID 16480170 DOI: 10.1080/02791072.2005.10399816  0.658
2005 Pettinati HM, Weiss RD, Dundon W, Miller WR, Donovan D, Ernst DB, Rounsaville BJ. A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. Journal of Studies On Alcohol. Supplement. 170-8; discussion 16. PMID 16223068 DOI: 10.15288/Jsas.2005.S15.170  0.323
2005 Weiss RD, Locastro JS, Swift R, Zweben A, Miller WR, Longabaugh R, Hosking JD. Use of a "psychotherapy with no pills" treatment condition as part of a combined pharmacotherapy-psychotherapy research study of alcohol dependence. Journal of Studies On Alcohol. Supplement. 43-9; discussion 33. PMID 16223055 DOI: 10.15288/Jsas.2005.S15.43  0.355
2005 Ziedonis DM, Smelson D, Rosenthal RN, Batki SL, Green AI, Henry RJ, Montoya I, Parks J, Weiss RD. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. Journal of Psychiatric Practice. 11: 315-39. PMID 16184072 DOI: 10.1097/00131746-200509000-00005  0.408
2005 Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS. Does recovery from substance use disorder matter in patients with bipolar disorder? The Journal of Clinical Psychiatry. 66: 730-5; quiz 808-9. PMID 15960566 DOI: 10.4088/Jcp.V66N0609  0.436
2005 Gelernter J, Panhuysen C, Weiss R, Brady K, Hesselbrock V, Rounsaville B, Poling J, Wilcox M, Farrer L, Kranzler HR. Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 136: 45-52. PMID 15909294 DOI: 10.1002/Ajmg.B.30189  0.315
2005 Kolodziej ME, Griffin ML, Najavits LM, Otto MW, Greenfield SF, Weiss RD. Anxiety disorders among patients with co-occurring bipolar and substance use disorders Drug and Alcohol Dependence. 80: 251-257. PMID 15876498 DOI: 10.1016/J.Drugalcdep.2005.04.003  0.672
2005 Weiss RD, Griffin ML, Gallop RJ, Najavits LM, Frank A, Crits-Christoph P, Thase ME, Blaine J, Gastfriend DR, Daley D, Luborsky L. The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients Drug and Alcohol Dependence. 77: 177-184. PMID 15664719 DOI: 10.1016/J.Drugalcdep.2004.08.012  0.616
2005 Weiss RD. Treating patients with bipolar disorder and substance dependence: lessons learned. Journal of Substance Abuse Treatment. 27: 307-12. PMID 15610832 DOI: 10.1016/J.Jsat.2004.10.001  0.457
2005 Weiss RD. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction (Abingdon, England). 99: 1382-92. PMID 15500591 DOI: 10.1111/J.1360-0443.2004.00884.X  0.383
2005 Potter JS, Hennessy G, Borrow JA, Greenfield SF, Weiss RD. Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug and Alcohol Dependence. 76: 213-5. PMID 15488345 DOI: 10.1016/J.Drugalcdep.2004.05.001  0.383
2004 Najavits LM, Sullivan TP, Schmitz M, Weiss RD, Lee CS. Treatment utilization by women with PTSD and substance dependence. The American Journal On Addictions. 13: 215-24. PMID 15370941 DOI: 10.1080/10550490490459889  0.605
2004 Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. Journal of Clinical Psychopharmacology. 24: 512-20. PMID 15349007 DOI: 10.1097/01.Jcp.0000138772.40515.70  0.439
2004 Najavits LM, Sonn J, Walsh M, Weiss RD. Domestic violence in women with PTSD and substance abuse. Addictive Behaviors. 29: 707-15. PMID 15135552 DOI: 10.1016/J.Addbeh.2004.01.003  0.609
2004 Humphreys K, Wing S, McCarty D, Chappel J, Gallant L, Haberle B, Horvath AT, Kaskutas LA, Kirk T, Kivlahan D, Laudet A, McCrady BS, McLellan AT, Morgenstern J, Townsend M, ... Weiss R, et al. Self-help organizations for alcohol and drug problems: toward evidence-based practice and policy. Journal of Substance Abuse Treatment. 26: 151-8; discussion 15. PMID 15063905 DOI: 10.1016/S0740-5472(03)00212-5  0.307
2004 Weiss RD, Kolodziej M, Griffin ML, Najavits LM, Jacobson LM, Greenfield SF. Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence Journal of Affective Disorders. 79: 279-283. PMID 15023508 DOI: 10.1016/S0165-0327(02)00454-8  0.66
2004 Hennessy GO, De Menil V, Weiss RD. Psychosocial treatments for cocaine dependence. Current Psychiatry Reports. 5: 362-4. PMID 13678556 DOI: 10.1007/S11920-003-0069-2  0.383
2004 Najavits LM, Ghinassi F, Van Horn A, Weiss RD, Siqueland L, Frank A, Thase ME, Luborsky L. Therapist Satisfaction With Four Manual-Based Treatments on a National Multisite Trial: An Exploratory Study. Psychotherapy: Theory, Research, Practice, Training. 41: 26-37. DOI: 10.1037/0033-3204.41.1.26  0.582
2004 Najavits LM, Gotthardt S, Weiss RD, Epstein M. Cognitive distortions in the dual diagnosis of PTSD and substance use disorder Cognitive Therapy and Research. 28: 159-172. DOI: 10.1023/B:Cotr.0000021537.18501.66  0.589
2003 Crits-Christoph P, Gibbons MB, Barber JP, Gallop R, Beck AT, Mercer D, Tu X, Thase ME, Weiss RD, Frank A. Mediators of outcome of psychosocial treatments for cocaine dependence. Journal of Consulting and Clinical Psychology. 71: 918-25. PMID 14516240 DOI: 10.1037/0022-006X.71.5.918  0.356
2003 Dickey B, Normand SL, Drake R, Weiss RD, Azeni H, Hanson A. Limiting inpatient substance use treatment: what are the consequences? Medical Care Research and Review : McRr. 60: 332-46. PMID 12971232 DOI: 10.1177/1077558703254691  0.423
2003 Weiss RD, Griffin ML, Mazurick C, Berkman B, Gastfriend DR, Frank A, Barber JP, Blaine J, Salloum I, Moras K. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use American Journal of Psychiatry. 160: 1320-1325. PMID 12832248 DOI: 10.1176/Appi.Ajp.160.7.1320  0.401
2003 Kanayama G, Cohane GH, Weiss RD, Pope HG. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? The Journal of Clinical Psychiatry. 64: 156-60. PMID 12633124 DOI: 10.4088/Jcp.V64N0208  0.46
2003 Greenfield SF, Hennessy G, Sugarman DE, Weiss RD. What general psychiatrists ask addiction psychiatrists: a review of 381 substance abuse consultations in a psychiatric hospital. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 12: 18-28. PMID 12623737 DOI: 10.1111/J.1521-0391.2003.Tb00536.X  0.449
2003 O'Leary G, Borrow J, Weiss RD. Opioid antagonists in the treatment of alcohol dependence. Current Psychiatry Reports. 3: 484-8. PMID 11707162 DOI: 10.1007/S11920-001-0042-X  0.346
2002 Greenfield SF, Kolodziej ME, Sugarman DE, Muenz LR, Vagge LM, He DY, Weiss RD. History of abuse and drinking outcomes following inpatient alcohol treatment: a prospective study. Drug and Alcohol Dependence. 67: 227-34. PMID 12127193 DOI: 10.1016/S0376-8716(02)00072-8  0.368
2002 Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H. Medical morbidity, mental illness, and substance use disorders. Psychiatric Services (Washington, D.C.). 53: 861-7. PMID 12096170 DOI: 10.1176/Appi.Ps.53.7.861  0.38
2002 O'Leary G, Weiss RD. Pharmacotherapies for cocaine dependence. Current Psychiatry Reports. 2: 508-13. PMID 11123003 DOI: 10.1007/S11920-000-0010-X  0.355
2001 Crits-Christoph P, Siqueland L, McCalmont E, Weiss RD, Gastfriend DR, Frank A, Moras K, Barber JP, Blaine J, Thase ME. Impact of psychosocial treatments on associated problems of cocaine-dependent patients Journal of Consulting and Clinical Psychology. 69: 825-830. PMID 11680559 DOI: 10.1037//0022-006X.69.5.825  0.426
2001 Barber JP, Luborsky L, Gallop R, Crits-Christoph P, Frank A, Weiss RD, Thase ME, Connolly MB, Gladis M, Foltz C, Siqueland L. Therapeutic alliance as a predictor of outcome and retention in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Journal of Consulting and Clinical Psychology. 69: 119-24. PMID 11302268 DOI: 10.1037//0022-006X.69.1.119  0.394
2000 Weiss RD, Kolodziej ME, Najavits LM, Greenfield SF, Fucito LM. Utilization of psychosocial treatments by patients diagnosed with bipolar disorder and substance dependence. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 9: 314-20. PMID 11256355 DOI: 10.1080/105504900750047364  0.686
2000 Weiss RD, Griffin ML, Gallop R, Luborsky L, Siqueland L, Frank A, Onken LS, Daley DC, Gastfriend DR. Predictors of self-help group attendance in cocaine dependent patients Journal of Studies On Alcohol. 61: 714-719. PMID 11022811 DOI: 10.15288/Jsa.2000.61.714  0.43
2000 Weiss RD, Greenfield SF, Griffin ML, Najavits LM, Fucito LM. The use of collateral reports for patients with bipolar and substance use disorders. The American Journal of Drug and Alcohol Abuse. 26: 369-78. PMID 10976663 DOI: 10.1081/Ada-100100250  0.626
2000 Weiss RD, Griffin ML, Gallop R, Onken LS, Gastfriend DR, Daley D, Crits-Christoph P, Bishop S, Barber JP. Self-help group attendance and participation among cocaine dependent patients Drug and Alcohol Dependence. 60: 169-177. PMID 10940544 DOI: 10.1016/S0376-8716(99)00154-4  0.35
2000 Weiss RD, Griffin ML, Greenfield SF, Najavits LM, Wyner D, Soto JA, Hennen JA. Group therapy for patients with bipolar disorder and substance dependence: Results of a pilot study Journal of Clinical Psychiatry. 61: 361-367. PMID 10847311 DOI: 10.4088/Jcp.V61N0507  0.657
2000 Greenfield SF, Hufford MR, Vagge LM, Muenz LR, Costello ME, Weiss RD. The relationship of self-efficacy expectancies to relapse among alcohol dependent men and women: A prospective study Journal of Studies On Alcohol. 61: 345-351. PMID 10757147 DOI: 10.15288/Jsa.2000.61.345  0.313
2000 Kolodziej ME, Weiss RD. Comorbid alcohol dependence and depression Current Opinion in Psychiatry. 13: 87-89. DOI: 10.1097/00001504-200001000-00015  0.341
2000 Najavits LM, Weiss RD, Shaw SR, Dierberger AE. Psychotherapists' views of treatment manuals. Professional Psychology: Research and Practice. 31: 404-408. DOI: 10.1037/0735-7028.31.4.404  0.585
2000 Weiss RD, Griffin ML, Mazurick C, Gallop R, Berkman B. 708 The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use Drug and Alcohol Dependence. 60. DOI: 10.1016/S0376-8716(00)90011-5  0.347
1999 Tohen M, Greenfield SF, Weiss RD, Zarate CA, Vagge LM. The effect of comorbid substance use disorders on the course of bipolar disorder: a review. Harvard Review of Psychiatry. 6: 133-41. PMID 10372281 DOI: 10.3109/10673229809000321  0.441
1999 Siqueland L, Horn A, Moras K, Woody G, Weiss R, Blaine J, Bishop S, Barber J, Thase M. Cocaine-induced mood disorder: Prevalence rates and psychiatric symptoms in an outpatient cocaine-dependent sample American Journal On Addictions. 8: 165-169. PMID 10365197 DOI: 10.1080/105504999305974  0.439
1999 Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, Muenz LR, Thase ME, Weiss RD, Gastfriend DR, Woody GE, Barber JP, Butler SF, Daley D, Salloum I, et al. Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Archives of General Psychiatry. 56: 493-502. PMID 10359461 DOI: 10.1001/Archpsyc.56.6.493  0.634
1999 Wines JD, Weiss RD. Opioid withdrawal during risperidone treatment. Journal of Clinical Psychopharmacology. 19: 265-7. PMID 10350033 DOI: 10.1097/00004714-199906000-00010  0.348
1999 Weiss RD, Najavits LM, Greenfield SF. A relapse prevention group for patients with bipolar and substance use disorders. Journal of Substance Abuse Treatment. 16: 47-54. PMID 9888121 DOI: 10.1016/S0740-5472(98)00011-7  0.673
1999 Najavits LM, Weiss RD, Shaw SR. A clinical profile of women with posttraumatic stress disorder and substance dependence. Psychology of Addictive Behaviors. 13: 98-104. DOI: 10.1037/0893-164X.13.2.98  0.644
1998 Siqueland L, Crits-Christoph P, Frank A, Daley D, Weiss R, Chittams J, Blaine J, Luborsky L. Predictors of dropout from psychosocial treatment of cocaine dependence Drug and Alcohol Dependence. 52: 1-13. PMID 9788001 DOI: 10.1016/S0376-8716(98)00039-8  0.432
1998 Najavits LM, Weiss RD, Shaw SR, Muenz LR. "Seeking safety": outcome of a new cognitive-behavioral psychotherapy for women with posttraumatic stress disorder and substance dependence. Journal of Traumatic Stress. 11: 437-56. PMID 9690186 DOI: 10.1023/A:1024496427434  0.667
1998 Weiss RD, Greenfield SF, Najavits LM, Soto JA, Wyner D, Tohen M, Griffin ML. Medication compliance among patients with bipolar disorder and substance use disorder Journal of Clinical Psychiatry. 59: 172-174. PMID 9590667 DOI: 10.4088/Jcp.V59N0405  0.657
1998 Najavits LM, Weiss RD, Reif S, Gastfriend DR, Siqueland L, Barber JP, Butler SF, Thase M, Blaine J. The Addiction Severity Index as a screen for trauma and posttraumatic stress disorder Journal of Studies On Alcohol. 59: 56-62. PMID 9498316 DOI: 10.15288/Jsa.1998.59.56  0.622
1998 Najavits LM, Gastfriend DR, Barber JP, Reif S, Muenz LR, Blaine J, Frank A, Crits-Christoph P, Thase M, Weiss RD. Cocaine dependence with and without PTSD among subjects in the national institute on drug abuse collaborative cocaine treatment study American Journal of Psychiatry. 155: 214-219. PMID 9464200 DOI: 10.1176/Ajp.155.2.214  0.661
1998 Weiss RD, Najavits LM, Greenfield SF, Soto JA, Shaw SR, Wyner D. Validity of substance use self-reports in dually diagnosed outpatients. The American Journal of Psychiatry. 155: 127-8. PMID 9433351 DOI: 10.1176/Ajp.155.1.127  0.655
1997 Najavits LM, Weiss RD, Shaw SR. The link between substance abuse and posttraumatic stress disorder in women. A research review. The American Journal On Addictions. 6: 273-83. PMID 9398925 DOI: 10.3109/10550499709005058  0.679
1997 Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, Muenz L, Thase ME, Weiss RD, Gastfriend DR, Woody G, Barber JP, Butler SF, Daley D, Bishop S, et al. The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods. Archives of General Psychiatry. 54: 721-6. PMID 9283507 DOI: 10.1001/Archpsyc.1997.01830200053007  0.658
1997 Weiss RD, Griffin ML, Hufford C, Muenz LR, Najavits LM, Jansson SB, Kogan J, Thompson HJ. Early prediction of initiation of abstinence from cocaine. Use of a craving questionnaire. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 6: 224-31. PMID 9256988 DOI: 10.3109/10550499709136989  0.602
1997 Weiss RD, Martinez-Raga J, Griffin ML, Greenfield SF, Hufford C. Gender differences in cocaine dependent patients: A 6 month follow-up study Drug and Alcohol Dependence. 44: 35-40. PMID 9031818 DOI: 10.1016/S0376-8716(96)01319-1  0.391
1997 Najavits LM, Weiss RD, Shaw SR. The Link Between Substance Abuse and Posttraumatic Stress Disorder in Women The American Journal On Addictions. 6: 273-283. DOI: 10.1111/J.1521-0391.1997.TB00408.X  0.597
1997 Weiss RD, Griffin ML, Hufford C, Muenz LR, Najavits LM, Jansson SB, Kogan J, Thompson HJ. Early Prediction of Initiation of Abstinence From Cocaine American Journal On Addictions. 6: 224-231. DOI: 10.1111/J.1521-0391.1997.Tb00401.X  0.327
1996 Weiss RD, Griffin ML, Najavits LM, Hufford C, Kogan J, Thompson HJ, Albeck JH, Bishop S, Daley DC, Mercer D, Siqueland L. Self-help activities in cocaine dependent patients entering treatment: results from NIDA collaborative cocaine treatment study. Drug and Alcohol Dependence. 43: 79-86. PMID 8957146 DOI: 10.1016/S0376-8716(96)01292-6  0.616
1996 Weiss RD, Martínez-Raga J, Hufford C. The significance of a coexisting opioid use disorder in cocaine dependence: an empirical study. The American Journal of Drug and Alcohol Abuse. 22: 173-84. PMID 8727053 DOI: 10.3109/00952999609001652  0.485
1996 Najavits LM, Weiss RD, Liese BS. Group cognitive-behavioral therapy for women with PTSD and substance use disorder. Journal of Substance Abuse Treatment. 13: 13-22. PMID 8699538 DOI: 10.1016/0740-5472(95)02025-X  0.655
1996 Barber JP, Frank A, Weiss RD, Blaine J, Siqueland L, Moras K, Calvo N, Chittams J, Mercer D, Salloum IM. Prevalence and Correlates of Personality Disorder Diagnoses among Cocaine Dependent Outpatients Journal of Personality Disorders. 10: 297-311. DOI: 10.1521/Pedi.1996.10.4.297  0.381
1995 Weiss RD, Greenfield SF, Najavits LM. Integrating psychological and pharmacological treatment of dually diagnosed patients. Nida Research Monograph. 150: 110-28. PMID 8742775  0.568
1995 Greenfield SF, Weiss RD, Tohen M. Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital. Community Mental Health Journal. 31: 265-77. PMID 7621663 DOI: 10.1007/Bf02188753  0.458
1995 Weiss RD, Najavits LM, Muenz LR, Hufford C. Twelve-month test-retest reliability of the structured clinical interview for DSM-III-R personality disorders in cocaine-dependent patients. Comprehensive Psychiatry. 36: 384-9. PMID 7497713 DOI: 10.1016/S0010-440X(95)90120-5  0.646
1995 Weiss RD, Griffin ML, Hufford C. Craving in hospitalized cocaine abusers as a predictor of outcome American Journal of Drug and Alcohol Abuse. 21: 289-301. PMID 7484980 DOI: 10.3109/00952999509002698  0.391
1995 Najavits LM, Griffin ML, Luborsky L, Frank A, Weiss RD, Liese BS, Thompson H, Nakayama E, Siqueland L, Daley D, Onken LS. Therapists' emotional reactions to substance abusers: A new questionnaire and initial findings. Psychotherapy: Theory, Research, Practice, Training. 32: 669-677. DOI: 10.1037/0033-3204.32.4.669  0.58
1994 Najavits LM, Weiss RD. The role of psychotherapy in the treatment of substance-use disorders. Harvard Review of Psychiatry. 2: 84-96. PMID 9384886 DOI: 10.3109/10673229409017121  0.665
1994 Najavits LM, Weiss RD. Variations in therapist effectiveness in the treatment of patients with substance use disorders: an empirical review. Addiction (Abingdon, England). 89: 679-88. PMID 8069169 DOI: 10.1111/J.1360-0443.1994.Tb00954.X  0.661
1994 Weiss RD, Hufford C, Mendelson JH. Serum prolactin levels and treatment outcome in cocaine dependence. Biological Psychiatry. 35: 573-4. PMID 8038302 DOI: 10.1016/0006-3223(94)90106-6  0.34
1993 Weiss RD, Mirin SM, Griffin ML, Gunderson JG, Hufford C. Personality disorders in cocaine dependence Comprehensive Psychiatry. 34: 145-149. PMID 8339531 DOI: 10.1016/0010-440X(93)90040-B  0.628
1992 Greenfield SF, Weiss RD, Griffin ML. Patients who use drugs during inpatient substance abuse treatment American Journal of Psychiatry. 149: 235-239. PMID 1734745 DOI: 10.1176/Ajp.149.2.235  0.386
1992 Weiss RD, Mirin SM, Frances RJ. Alcohol & drug abuse. The myth of the typical dual diagnosis patient. Hospital & Community Psychiatry. 43: 107-8. PMID 1572604 DOI: 10.1176/Ps.43.2.107  0.435
1992 Weiss RD, Griffin ML, Mirin SM. Drug abuse as self-medication for depression: An empirical study American Journal of Drug and Alcohol Abuse. 18: 121-129. PMID 1562010 DOI: 10.3109/00952999208992825  0.349
1992 Hudson JI, Weiss RD, Pope HG, McElroy SK, Mirin SM. Eating disorders in hospitalized substance abusers. The American Journal of Drug and Alcohol Abuse. 18: 75-85. PMID 1562008 DOI: 10.3109/00952999209001613  0.426
1992 Weiss RD, Mirin SL, Griffin ML. Methodological considerations in the diagnosis of coexisting psychiatric disorders in substance abusers British Journal of Addiction. 87: 179-187. PMID 1554994 DOI: 10.1111/J.1360-0443.1992.Tb02691.X  0.461
1992 Weiss RD, Griffin ML, Hufford C. Severity of cocaine dependence as a predictor of relapse to cocaine use American Journal of Psychiatry. 149: 1595-1596. PMID 1415833 DOI: 10.1176/Ajp.149.11.1595  0.348
1992 Weiss RD, Collins DA. Substance Abuse and Psychiatric Illness:The Dually Diagnosed Patient American Journal On Addictions. 1: 93-99. DOI: 10.3109/10550499209004010  0.462
1991 Mirin SM, Weiss RD, Griffin ML, Michael JL. Psychopathology in drug abusers and their families Comprehensive Psychiatry. 32: 36-51. PMID 2001619 DOI: 10.1016/0010-440X(91)90068-N  0.475
1990 Teoh SK, Mendelson JH, Mello NK, Weiss R, McElroy S, McAfee B. Hyperprolactinemia and risk for relapse of cocaine abuse. Biological Psychiatry. 28: 824-8. PMID 2257288 DOI: 10.1016/0006-3223(90)90517-6  0.335
1990 Weiss R, Mirin S. Psychological and Pharmacological Treatment Strategies in Cocaine Dependence Annals of Clinical Psychiatry. 2: 239-243. DOI: 10.3109/10401239009147951  0.417
1989 Weiss RD, Gawin FH. Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers. The American Journal of Medicine. 85: 879-80. PMID 3195611 DOI: 10.1016/S0002-9343(88)80042-1  0.353
1989 Griffin ML, Weiss RD, Mirin SM, Lange U. A Comparison of Male and Female Cocaine Abusers Archives of General Psychiatry. 46: 122-126. PMID 2913971 DOI: 10.1001/Archpsyc.1989.01810020024005  0.373
1989 Weiss RD, Griffin ML, Mirin SM. Diagnosing major depression in cocaine abusers: The use of depression rating scales Psychiatry Research. 28: 335-343. PMID 2762434 DOI: 10.1016/0165-1781(89)90214-X  0.312
1989 Adelman SA, Weiss RD. What is therapeutic about inpatient alcoholism treatment? Hospital & Community Psychiatry. 40: 515-9. PMID 2656485 DOI: 10.1176/Ps.40.5.515  0.366
1989 Weiss RD. The Treatment of Chemical Dependence-Reply Jama: the Journal of the American Medical Association. 261: 3239. DOI: 10.1001/Jama.1989.03420220053007  0.423
1989 Griffin ML, Weiss RD, Mirin SM, Lange U. Gauging Recovery Rates Requires Test Norms-Reply Archives of General Psychiatry. 46: 1054. DOI: 10.1001/Archpsyc.1989.01810110096018  0.336
1988 Mendelson JH, Teoh SK, Lange U, Mello NK, Weiss R, Skupny A, Ellingboe J. Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. The American Journal of Psychiatry. 145: 1094-8. PMID 3414852 DOI: 10.1176/Ajp.145.9.1094  0.301
1988 Weiss RD, Mirin SM, Griffin ML, Michael JL. A comparison of alcoholic and nonalcoholic drug abusers Journal of Studies On Alcohol. 49: 510-515. PMID 3266278 DOI: 10.15288/Jsa.1988.49.510  0.341
1988 Weiss RD, Mirin SM, Griffin ML, Michael JL. Psychopathology in cocaine abusers changing trends Journal of Nervous and Mental Disease. 176: 719-725. PMID 3199107 DOI: 10.1097/00005053-198812000-00004  0.424
1988 Weiss RD. Relapse to Cocaine Abuse After Initiating Desipramine Treatment Jama: the Journal of the American Medical Association. 260: 2545. DOI: 10.1001/Jama.1988.03410170093041  0.358
1987 Weiss RD, Mirin SM, Michael JL, Sollogub AC. Psychopathology in chronic cocaine abusers. The American Journal of Drug and Alcohol Abuse. 12: 17-29. PMID 3788897 DOI: 10.3109/00952998609083740  0.429
1987 Griffin ML, Weiss RD, Mirin SM, Wilson H, Bouchard-Voelk B. The use of the diagnostic interview schedule in drug-dependent patients American Journal of Drug and Alcohol Abuse. 13: 281-291. PMID 3687891 DOI: 10.3109/00952998709001514  0.461
1987 Weiss RD, Tilles DS, Goldenheim PD, Mirin SM. Decreased single breath carbon monoxide diffusing capacity in cocaine freebase smokers. Drug and Alcohol Dependence. 19: 271-6. PMID 3595450 DOI: 10.1016/0376-8716(87)90047-0  0.303
1986 Mirin SM, Weiss RD. Affective Illness in Substance Abusers Psychiatric Clinics of North America. 9: 503-514. DOI: 10.1016/S0193-953X(18)30609-9  0.428
1986 Weiss RD, Mirin SM. Subtypes of Cocaine Abusers Psychiatric Clinics of North America. 9: 491-501. DOI: 10.1016/S0193-953X(18)30608-7  0.382
1985 Weiss RD, Pope HG, Mirin SM. Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline. Drug and Alcohol Dependence. 15: 69-72. PMID 4017880 DOI: 10.1016/0376-8716(85)90031-6  0.433
1982 Mirin SM, Weiss RD, Michael J. Alcohol Abuse in Patients Dependent on Other Drugs Psychiatric Annals. 12: 430-433. DOI: 10.3928/0048-5713-19820401-11  0.341
Show low-probability matches.